Evidence map›Paper›PMID 38348670›Full record

ArticleCirculation. Heart failure2024

Failing to Make the Grade: Conventional Cardiac Allograft Rejection Grading Criteria Are Inadequate for Predicting Rejection Severity.

Sara Arabyarmohammadi, Cai Yuan, Vidya Sankar Viswanathan, Priti Lal, Michael D Feldman, Pingfu Fu, Kenneth B Margulies, Anant Madabhushi, Eliot G Peyster

Open access · greenAbstract read
In one paragraph

Article in Circulation. Heart failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Sara ArabyarmohammadiDepartment Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta (S.A., C.Y., V.S.V.).
Cai YuanDepartment Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta (S.A., C.Y., V.S.V.).
Vidya Sankar ViswanathanDepartment Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta (S.A., C.Y., V.S.V.).ORCID 0000-0003-1578-6248
Priti LalDepartment of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania (P.L.), Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Michael D FeldmanDepartment of Pathology and Laboratory Medicine, School of Medicine, Indiana University, Indianapolis (M.D.F.).
Pingfu FuDepartment of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, OH (P.F.).ORCID 0000-0002-2334-5218
Kenneth B MarguliesCardiovascular Research Institute, Department of Medicine (K.B.M., E.G.P.), Perelman School of Medicine, University of Pennsylvania, Philadelphia.ORCID 0000-0002-8093-4465
Anant MadabhushiDepartment of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta (A.M.).ORCID 0000-0002-5741-0399
Eliot G PeysterCardiovascular Research Institute, Department of Medicine (K.B.M., E.G.P.), Perelman School of Medicine, University of Pennsylvania, Philadelphia.ORCID 0000-0002-3350-3136
Georgia Institute of Technology · USUniversity of Pennsylvania · USCase Western Reserve University · USHospital of the University of Pennsylvania · USIndiana University – Purdue University Indianapolis · US

Funding

Computer-Assisted Histologic Evaluation of Cardiac Allograft RejectionR01HL151277 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MADABHUSHI, ANANT, MARGULIES, KENNETH BER · 2020 to 2023
$3.2M
Oral Cavity Quantitative Histomorphometric Risk Classifier (OHbIC) in Oral Cavity Squamous Cell Carcinoma (OC-SCC)R01CA249992 · NCI · EMORY UNIVERSITY · PI LEWIS, JAMES, MADABHUSHI, ANANT · 2021 to 2025
$3.2M
Prostate cancer risk stratification via computational 3D pathologyR01CA268207 · NCI · UNIVERSITY OF WASHINGTON · PI Jonathan T.C. Liu, Anant Madabhushi · 2022 to 2026
$3.1M
Quantitative Histomorphometric Risk Classifier (QuHbIC) in HPV + Oropharyngeal CarcinomaR01CA220581 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI KOYFMAN, SHLOMO, LEWIS, JAMES · 2018 to 2023
$3.1M
Computerized Histologic Risk Predictor (CHiRP) for Early Stage Lung CancersR01CA216579 · NCI · EMORY UNIVERSITY · PI FU, PINGFU, LLOYD, MARK · 2018 to 2023
$3.1M
Prognostic and Predictive Digital Tissue Image Assay for Prostate CancerR01CA268287 · NCI · EMORY UNIVERSITY · PI GUPTA, SHILPA, LAL, PRITI · 2022 to 2025
$3.0M
MR Fingerprinting and Computerized Decision Support for Prostate CancerR01CA208236 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GULANI, VIKAS, PONSKY, LEE EVAN · 2017 to 2022
$3.0M
RADIOMIC APPROACHES TO IMPROVE TARGETING FOR ATRIAL FIBRILLATION CATHETER ABLATIONR01HL158071 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI BARNARD, JOHN, CHUNG, MINA KAY · 2021 to 2024
$2.9M
Novel Radiomics for Predicting Response to Immunotherapy for Lung CancerR01CA257612 · NCI · EMORY UNIVERSITY · PI Anant Madabhushi, Vamsidhar Velcheti · 2021 to 2026
$2.7M
An AI-enabled Digital Pathology Platform for Multi-Cancer Diagnosis, Prognosis and Prediction of Therapeutic BenefitU01CA269181 · NCI · EMORY UNIVERSITY · PI Anant Madabhushi, tanuja shet · 2022 to 2026
$2.5M
HistoTools: A suite of digital pathology tools for quality control, annotation and dataset identificationU01CA239055 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI JANOWCZYK, ANDREW ROBERT, MADABHUSHI, ANANT · 2019 to 2022
$1.0M
Personalized Rejection Risk Assessment in Cardiac TransplantationK08HL159344 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI PEYSTER, ELIOT · 2021 to 2024
$667k
BLRD VA I01 BX004121BLRD VA IK6 BX006185CSRD VA I01 CX002622NCI NIH HHS R01 CA208236NCI NIH HHS R01 CA216579NCI NIH HHS R01 CA220581NCI NIH HHS R01 CA249992NCI NIH HHS R01 CA257612NCI NIH HHS R01 CA268207NCI NIH HHS R01 CA268287NCI NIH HHS U01 CA239055NCI NIH HHS U01 CA269181NHLBI NIH HHS K08 HL159344NHLBI NIH HHS R01 HL151277NHLBI NIH HHS R01 HL158071
6 · The paper itself

Abstract

backgroundCardiac allograft rejection is the leading cause of early graft failure and is a major focus of postheart transplant patient care. While histological grading of endomyocardial biopsy samples remains the diagnostic standard for acute rejection, this standard has limited diagnostic accuracy. Discordance between biopsy rejection grade and patient clinical trajectory frequently leads to both overtreatment of indolent processes and delayed treatment of aggressive ones, spurring the need to investigate the adequacy of the current histological criteria for assessing clinically important rejection outcomes.

methodsN=2900 endomyocardial biopsy images were assigned a rejection grade label (high versus low grade) and a clinical trajectory label (evident versus silent rejection). Using an image analysis approach, n=370 quantitative morphology features describing the lymphocytes and stroma were extracted from each slide. Two models were constructed to compare the subset of features associated with rejection grades versus those associated with clinical trajectories. A proof-of-principle machine learning pipeline-the cardiac allograft rejection evaluator-was then developed to test the feasibility of identifying the clinical severity of a rejection event.

resultsThe histopathologic findings associated with conventional rejection grades differ substantially from those associated with clinically evident allograft injury. Quantitative assessment of a small set of well-defined morphological features can be leveraged to more accurately reflect the severity of rejection compared with that achieved by the International Society of Heart and Lung Transplantation grades.

conclusionsConventional endomyocardial samples contain morphological information that enables accurate identification of clinically evident rejection events, and this information is incompletely captured by the current, guideline-endorsed, rejection grading criteria.

Indexed as

Heart FailureHeart TransplantationAllograftsBiopsyGraft RejectionHeartHumansMyocardiumallograftartificial intelligencegraft rejectionheart transplantationlymphocytesmachine learningpathology

Identifiers

PMID38348670
PMCPMC10940208
OpenAlexW4391785832

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.